ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 083,64
0,48%
DAX
17 896,50
-0,14%
Brent Oil
83,225
-0,38%
Bitcoin
59 114,58
1,51%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Osiris Therape (MM) (OSIR)

  7. Osiris Therape (MM) (OSIR) Actualités

OSIR

Osiris Therapeutics, Inc. (OSIR)

Osiris Therape (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OSIR
DateHeureSourceTitreSymboleSociété
29/04/201922h13Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:OSIROsiris Therape (MM)
17/04/201915h48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:OSIROsiris Therape (MM)
17/04/201915h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
17/04/201915h19Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
17/04/201915h15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSIROsiris Therape (MM)
17/04/201915h05GlobeNewswire Inc.Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plcNASDAQ:OSIROsiris Therape (MM)
17/04/201912h08Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
17/04/201912h08Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
20/03/201912h43Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OSIROsiris Therape (MM)
20/03/201912h33Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:OSIROsiris Therape (MM)
15/03/201923h13PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
15/03/201914h03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OSIROsiris Therape (MM)
12/03/201922h10Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OSIROsiris Therape (MM)
12/03/201922h03Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:OSIROsiris Therape (MM)
12/03/201918h14PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
12/03/201914h33PR Newswire (US)Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
12/03/201914h00GlobeNewswire Inc.Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plcNASDAQ:OSIROsiris Therape (MM)
28/02/201915h00GlobeNewswire Inc.Predictive Technology Group Names Jay M. Moyes to Its Board of DirectorsNASDAQ:OSIROsiris Therape (MM)
29/11/201822h24Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OSIROsiris Therape (MM)
26/11/201822h30GlobeNewswire Inc.Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive OfficerNASDAQ:OSIROsiris Therape (MM)
07/11/201822h25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OSIROsiris Therape (MM)
07/11/201822h15GlobeNewswire Inc.Osiris Therapeutics, Inc Reports Third Quarter 2018 ResultsNASDAQ:OSIROsiris Therape (MM)
30/10/201821h30GlobeNewswire Inc.Osiris Therapeutics, Inc. to Present Advanced Clinical and Scientific Abstracts at Symposium on Advanced Wound Care (SAWC) Fa...NASDAQ:OSIROsiris Therape (MM)
02/10/201822h30GlobeNewswire Inc.Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Demonstrating That Lyopreservation Method Developed for Living ...NASDAQ:OSIROsiris Therape (MM)
17/09/201823h00GlobeNewswire Inc.Osiris Therapeutics, Inc. Announces GrafixPL PRIME™ Launches October 1, 2018NASDAQ:OSIROsiris Therape (MM)
27/08/201822h30GlobeNewswire Inc.Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Comparing the Efficacy of Viable Cryopreserved Placental Membra...NASDAQ:OSIROsiris Therape (MM)
31/07/201816h33Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)NASDAQ:OSIROsiris Therape (MM)
27/07/201822h05Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:OSIROsiris Therape (MM)
25/07/201822h33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OSIROsiris Therape (MM)
11/05/201820h31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OSIROsiris Therape (MM)
 Showing the most relevant articles for your search:NASDAQ:OSIR

Dernières Valeurs Consultées

EU
DG
Vinci
EU
HO
Thales
NYSE
MCD
McDonalds
EU
BNP
BNP Paribas
NYSE
NKE
Nike
EU
CAP
Capgemini
EU
VK
Vallourec
NASDAQ
MSFT
Microsoft
FTSE
UKX
FTSE 100
NASDAQ
GOOGL
Alphabet
EU
MC
Lvmh Moet Hennessy Louis...
EU
AI
Air Liquide
EU
ML
Michelin
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés